The U.S. Department of Justice continues to sharpen its enforcement approach to the Foreign Corrupt Practices Act (FCPA), raising the bar for corporate compliance
programs, internal investigations, and cooperationexpectations.
This session will unpack the DOJ’s updated enforcement guidelines and priorities, offering practical guidance for legal and compliance leaders tasked with managing
corruption risk across global operations.
Kees van Ophem
Helen Aldridge
Giuseppe Deleonardis
Kersten Schmahl
Kersten Schmahl is Senior Director Ethics & Compliance Intercontinental at CSL, a global listed biotech company. He previously held various international Ethics & Compliance leadership positions with both listed and privately-held pharmaceutical, biotech and medical technology companies being based in Germany, Switzerland, and Sweden.
Kersten graduated from the University of St. Gallen, Switzerland, and Leuphana University in Luneburg, Germany. At the latter University, he has teaching assignments for Compliance & Investigations in Corporate Practice since 2009. Kersten is also a standing co-author for the chapter “Compliance in the Pharmaceutical & Medical Technology Industry” in the Handbook of Corporate Legal Management – Manual for Corporate Compliance in Germany.